Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Rondard

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Frontiers in Endocrinology|April 19, 2013
PROK2/PROKR2 Signaling and Kallmann SyndromeCatherine Dodé, Philippe Rondard
Current Opinion in Pharmacology|December 23, 2014
Dynamics and modulation of metabotropic glutamate receptorsPhilippe Rondard, Jean-Philippe Pin
Neuroscience|June 27, 2024
Heterodimers Revolutionize the Field of Metabotropic Glutamate ReceptorsKawthar Belkacemi, Philippe Rondard, Jean-Philippe Pin, et al.
Frontiers in Pharmacology|February 28, 2014
Complex GABAB receptor complexes: how to generate multiple functionally distinct units from a single receptorChanjuan Xu, Wenhua Zhang, Philippe Rondard, et al.
Trends in Pharmacological Sciences|November 6, 2025
Nanobodies: a new paradigm for brain disorder therapiesPierre-André Lafon, Laurent Prézeau, Jean-Philippe Pin, et al.
Molecular and Cellular Endocrinology|March 9, 2019
GPCR interaction as a possible way for allosteric control between receptorsJean-Philippe Pin, Julie Kniazeff, Laurent Prézeau, et al.
Pharmacology & Therapeutics|January 25, 2011
Dimers and beyond: The functional puzzles of class C GPCRsJulie Kniazeff, Laurent Prézeau, Philippe Rondard, et al.
Neuropharmacology|August 18, 2010
The complexity of their activation mechanism opens new possibilities for the modulation of mGlu and GABAB class C G protein-coupled receptorsPhilippe Rondard, Cyril Goudet, Julie Kniazeff, et al.
The Journal of Biological Chemistry|September 15, 2007
Activation of a dimeric metabotropic glutamate receptor by intersubunit rearrangementCarsten Brock, Nadia Oueslati, Stéphan Soler, et al.
International Journal of Molecular Sciences|February 11, 2023
Targeting the Brain with Single-Domain Antibodies: Greater Potential Than Stated So Far?Mireille Elodie Tsitokana, Pierre-André Lafon, Laurent Prézeau, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Frontiers in Endocrinology|April 19, 2013
PROK2/PROKR2 Signaling and Kallmann SyndromeCatherine Dodé, Philippe Rondard
Current Opinion in Pharmacology|December 23, 2014
Dynamics and modulation of metabotropic glutamate receptorsPhilippe Rondard, Jean-Philippe Pin
Neuroscience|June 27, 2024
Heterodimers Revolutionize the Field of Metabotropic Glutamate ReceptorsKawthar Belkacemi, Philippe Rondard, Jean-Philippe Pin, et al.
Frontiers in Pharmacology|February 28, 2014
Complex GABAB receptor complexes: how to generate multiple functionally distinct units from a single receptorChanjuan Xu, Wenhua Zhang, Philippe Rondard, et al.
Trends in Pharmacological Sciences|November 6, 2025
Nanobodies: a new paradigm for brain disorder therapiesPierre-André Lafon, Laurent Prézeau, Jean-Philippe Pin, et al.
Molecular and Cellular Endocrinology|March 9, 2019
GPCR interaction as a possible way for allosteric control between receptorsJean-Philippe Pin, Julie Kniazeff, Laurent Prézeau, et al.
Pharmacology & Therapeutics|January 25, 2011
Dimers and beyond: The functional puzzles of class C GPCRsJulie Kniazeff, Laurent Prézeau, Philippe Rondard, et al.
Neuropharmacology|August 18, 2010
The complexity of their activation mechanism opens new possibilities for the modulation of mGlu and GABAB class C G protein-coupled receptorsPhilippe Rondard, Cyril Goudet, Julie Kniazeff, et al.
The Journal of Biological Chemistry|September 15, 2007
Activation of a dimeric metabotropic glutamate receptor by intersubunit rearrangementCarsten Brock, Nadia Oueslati, Stéphan Soler, et al.
International Journal of Molecular Sciences|February 11, 2023
Targeting the Brain with Single-Domain Antibodies: Greater Potential Than Stated So Far?Mireille Elodie Tsitokana, Pierre-André Lafon, Laurent Prézeau, et al.
Pageof 8